{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:02:53Z","timestamp":1768968173488,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.brachy.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T13:31:28Z","timestamp":1600349488000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early outcomes after definitive chemoradiation therapy with Vienna\/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A\u00a0single-institution experience"],"prefix":"10.1016","volume":"20","author":[{"given":"A.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Vargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"Courtney-Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-1575","authenticated-orcid":false,"given":"B.C.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3802\/jgo.2017.28.e34","article-title":"Randomized study between radical surgery and radiotherapy for the treatment of stage IB\u2013IIA cervical cancer: 20-year update","volume":"28","author":"Landoni","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib3","first-page":"1606","article-title":"National cancer data base analysis of radiation therapy consolidation modality for cervical cancer: The impact of new technological advancements","volume":"18","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2019.12.032","article-title":"Declining brachytherapy utilization for cervical cancer patients - have we reversed the trend?","volume":"156","author":"Schad","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2016.09.009","article-title":"Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer","volume":"143","author":"Robin","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2012.05.033","article-title":"Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: Long-term results","volume":"85","author":"Pinn-Bingham","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2006.09.002","article-title":"High-dose-rate interstitial brachytherapy for gynecologic malignancies","volume":"5","author":"Beriwal","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.brachy.2010.02.071","article-title":"New Vienna applicator design for distal parametrial disease in cervical cancer","volume":"9","author":"Berger","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.meddos.2019.04.001","article-title":"Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy","volume":"45","author":"Schnell","year":"2020","journal-title":"Med Dosim"},{"key":"10.1016\/j.brachy.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.brachy.2018.05.009","article-title":"Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results","volume":"17","author":"Walter","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2006.04.041","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results","volume":"66","author":"Dimopoulos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijrobp.2014.10.053","article-title":"MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: The university of Pittsburgh experience","volume":"91","author":"Gill","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.brachy.2014.02.247","article-title":"Extended clinical outcomes of 3D high-dose-rate intracavitary brachytherapy with MRI-based planning for treatment of cervical cancer","volume":"13","author":"Gill","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiolo","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00259-018-4077-1","article-title":"Prognostic value of posttreatment 18F-FDG PET\/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: An analysis of intensity- and volume-based PET parameters","volume":"45","author":"Lima","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2018.01.092","article-title":"Use of functional magnetic resonance imaging in cervical cancer patients with incomplete response on positron emission tomography\/computed tomography after image-based high-dose-rate brachytherapy","volume":"102","author":"Kalash","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: Results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2019.08.004","article-title":"Vienna-II ring applicator for distal parametrial\/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome","volume":"141","author":"Mahantshetty","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijrobp.2018.12.042","article-title":"Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 239 Women: Can dose overcome poor response?","volume":"104","author":"Horne","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.08.006_bib20","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.brachy.2019.04.075","article-title":"Risk of ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer","volume":"18","author":"Rodr\u00edguez-L\u00f3pez","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.08.006_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120301811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120301811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:19Z","timestamp":1761531319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472120301811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1538472120301811"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.08.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early outcomes after definitive chemoradiation therapy with Vienna\/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A\u00a0single-institution experience","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}